Recent Articles

• 
  AI Healthcare

  KMI Joins Government Medical AI Talent Training, Expands AI Screening Education

  At the “2026 Medical AI Healthcare Workforce Job Training Project Kick-off” held at the Korea Human Resource Development Institute for Health and Welfare on April 30, (from left) Bae Nam-young, Acting President of the Korea Human Resource Development Institute for Health and Welfare, Kim Chan-woong,

  2026.05.19
• 
  Biopharma

  Innovation Is K-Bio’s Biggest Edge, Combo Keytruda Trials Surge

  “The greatest strength of the Korean bio ecosystem is that it combines both the scale and quality of innovation. It was impressive to see the exploration of new biological mechanisms or approaches and the active willingness to take on more complex challenges.” At MSD’s “Partnering Day,” held at COEX

  2026.05.19
• 
  MedTech

  Depression-Treating Lens Aims to Heal Through Eyes

  In experiments, the research team confirmed that the contact lenses it developed produced antidepressant treatment effects. Cell Reports Physical Science An antidepressant contact lens with effectiveness comparable to that of conventional antidepressant drugs has been developed. Electrodes embedded

  2026.05.18
• 
  Vaccine

  Hantavirus With 50% Fatality Rate Lacks Vaccine

  Electron microscope image of hantavirus. It is transmitted through rodent excreta, and with no approved vaccines or treatments available, its development is urgently needed worldwide. Provided by the U.S. Centers for Disease Control and Prevention (CDC) Confirmed cases of Andes virus, a type of hant

  2026.05.18
• 
  Biotech

  Alteogen Wins First Korean Biosimilar Approval, Eyes KOSDAQ No. 1 Reclaim

  Alteogen headquarters. Courtesy of Alteogen Alteogen has obtained its first biosimilar marketing authorization in Korea.Biopharmaceutical platform company Alteogen announced through a disclosure on the 15th that it has received marketing authorization from the Ministry of Food and Drug Safety (MFDS)

  2026.05.15
• 
  Global Business

  GC Biopharma, Merck Germany Sign Biologics Production Pact

  Shin Woong, Head of Operations at GC Biopharma (left), and Kim Young-im, Managing Director of Process Solutions Business at Merck Life Science, pose for a commemorative photo after signing a business agreement. Provided by GC Biopharma GC Biopharma announced on the 14th that it has signed a strategi

  2026.05.14
• 
  Pharmaceutical R&D

  MediPost Says Kartistem Succeeds in Japan Phase 3 Trial

  The stem cell therapy for osteoarthritis “Cartistem,” which has recorded cumulative domestic sales of KRW 140.3 billion and has been administered to more than 30,000 patients, has taken its first step toward overseas expansion 14 years after commercialization. Stem cell bio company Medipost announce

  2026.05.14
• 
  Global Business

  MediPost’s Cartistem Succeeds in Japan Phase 3 Trial

  The stem cell therapy for osteoarthritis “Cartistem,” which has recorded cumulative domestic sales of KRW 140.3 billion and has been administered to more than 30,000 patients, has taken its first step toward overseas expansion 14 years after commercialization. Stem cell bio company Medipost announce

  2026.05.13
• 
  MedTech

  Spine Treatment in 15 Minutes: Minimally Invasive Advances

  Director Park Chan-hong of Daegu Wooridul Hospital performing neuroplasty. Provided by Daegu Wooridul Hospital Wooridul Hospital developed the world’s first endoscopic lumbar disc removal surgery in 1992 and expanded and advanced this technique to treat complex cervical and thoracic disc conditions,

  2026.05.13
• 
  Biopharma

  Boryeong Holdings, Partners to Merge, Form Single Parent

  Boryung’s anticancer drug production facility at the Boryung Yesan Campus in Yesan, South Chungcheong Province. Courtesy of Boryung There has been a quiet but meaningful change in the governance structure of Boryung Co., Ltd., a domestic pharmaceutical company. On 1 May, Boryung Holdings absorbed Bo

  2026.05.13